Trial intelligence / Profile preview

Statin loading and antiplatelet response during coronary angioplasty with stenting

2010-024210-65Phase 2Terminated

Sponsor
Fondazione Centro San Raffaele
Start
Mar 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in coronary arteriosclerosis comparing Atorvastatin loading dose with Rosuvastatin loading dose (2 arms). Primary endpoint: Change in platelet reactivity. Started Mar 2012; status: terminated.

02

Drugs

atorvastatinrosuvastatin
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2010-024210-65.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024210-65.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call